Impact of Centralizing Care for Genitourinary Malignancies to High-volume Providers: A Systematic Review
Stephen B. Williams(Cedars-Sinai Medical Center), James W.F. Catto(University of Sheffield), Quoc‐Dien Trinh(University of Pittsburgh Medical Center), Mohamed D. Ray-Zack, Neal D. Shore(Carolina Urologic Research Center), Hogan K. Hudgins(The University of Texas Medical Branch at Galveston), Jan Oldenburg(Akershus University Hospital), Timothy O’Brien, Manfred P. Wirth(University Hospital Carl Gustav Carus), Paul L. Nguyen(Beth Israel Deaconess Medical Center)
Cited by 102
Related Papers
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
|The Lancet Oncology|2015|1.4k
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
|Journal of the American College of Cardiology|1996|1k
Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo
|Circulation|1998|804
Changes in circulating microRNA levels associated with prostate cancer
|British Journal of Cancer|2012|717
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694